Efficacy and Safety of Ocrelizumab in Patients with...

Multiple Sclerosis and Related Disorders 2020 / 01 Vol. 37

Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis with a Suboptimal Response to Previous Disease-Modifying Therapies (1-Year Interim Results)

Vermersch, Patrick, Erälinna, Juha-Pekka, Nicholas, Richard, Oreja-Guevara, Celia, Siva, Aksel, Van Wijmeersch, Bart, Wiendl, Heinz, Buffels, Regine, Kuhelj, Robert, Wei, Wei
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
37
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2019.11.063
Date:
January, 2020
File:
PDF, 102 KB
2020
Conversion to is in progress
Conversion to is failed